| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.16 | 0.0009 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.002 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.15 | 0.002 |